Intellia Therapeutics Inc (NTLA) USD0.0001

Sell:$13.16Buy:$13.24Price decreased$0.28 (2.08%)

NASDAQ:Price increased0.89%
Market closed |
Prices delayed by at least 15 minutes
Sell:$13.16
Buy:$13.24
Change:Price decreased$0.28 (2.08%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$13.16
Buy:$13.24
Change:Price decreased$0.28 (2.08%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$13.26
Previous close$13.48
Market cap$1.47bn
P/E ratio-
Volume1,697,888
Dividend yield0.00%
EMS-

Company information

Intellia Therapeutics, Inc. is a clinical-stage gene editing company focused on developing medicine with CRISPR-based therapies and other core technologies. CRISPR/Cas9 is a gene editing technology that leverages the ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue133.06m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.